V2 Trial: A phase I study of venetoclax and CPX-351 for young patients with relapsed/refractory acute leukemia.Laura Agresta, Maureen Megan O'Brien,Eric Justin O'Brien,Robin Elizabeth Norris,Erin Haag Breese,Karen Cristly Burns,Benjamin Mizukawa,Thomas D. Ryan,Pankaj B. Desai, A. A. Vinks,H. Leighton Grimes,Michael Absalon,John Peter PerentesisJOURNAL OF CLINICAL ONCOLOGY(2021)引用 1|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要